[Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma].
Hegenbart
U
U
Goldschmidt
H
H
D000686:Amyloidosis / Q000188:drug therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D007145:Immunoglobulin kappa-Chains; D007410:Intestinal Diseases / Q000188:drug therapy; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D010954:Plasmacytoma / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction; D013272:Stomach Diseases / Q000188:drug therapy
D007145:Immunoglobulin kappa-Chains; D011239:Prednisolone; D008558:Melphalan
Gastrointestinale Amyloidose bei IgG-kappa-Leicht-ketten-Plasmozytom.